Mirtogenol&reg; potentiates latanoprost in lowering intraocular pressure and improves ocular blood flow in asymptomatic subjects

Código QR

Mirtogenol&reg; potentiates latanoprost in lowering intraocular pressure and improves ocular blood flow in asymptomatic subjects

Robert D Steigerwalt Jr1, Gianni Belcaro1, Paolo Morazzoni2, Ezio Bombardelli2, Carolina Burki3, Frank Sch&ouml;nlau4 1Department of Biomedical Sciences, University of Chieti-Pescara, San Valentino, Italy; 2Indena S.p.A. Scientific Department, Milan, Italy; 3Horphag Research (UK) Ltd., Genev...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Robert D Steigerwalt Jr, Gianni Belcaro, Paolo Morazzoni, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/f006189deaa4460a93eedfacea0c2992
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

One month use of Systane&reg; improves ocular surface parameters in subjects with moderate symptoms of ocular dryness
por: Piera Versura, et al.
Publicado: (2008)

Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan® and Arulatan®) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
por: Brant Fernandes RA, et al.
Publicado: (2019)

24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost
por: Yoshimi Nakamura, et al.
Publicado: (2009)

Spectacle independence and subjective satisfaction of ReSTOR&reg; multifocal intraocular lens after cataract or presbyopia surgery in two European countries
por: B&eacute;atrice Cochener, et al.
Publicado: (2010)

Systane&reg; lubricant eye drops in the management of ocular dryness
por: Benelli U
Publicado: (2011)

Densiron&reg; 68 as an intraocular tamponade for complex inferior retinal detachments
por: Hussain RN, et al.
Publicado: (2011)

The effect of intravitreal bevacizumab (Avastin&reg;) on ocular pulse amplitude in neovascular age-related macular degeneration
por: Ehud Rechtman, et al.
Publicado: (2011)

Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review
por: Andrea Russo, et al.
Publicado: (2009)

Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
por: Gregory Katz, et al.
Publicado: (2010)

Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension
por: Pacella F, et al.
Publicado: (2012)

Tolerability and effectiveness of preservative-free dorzolamide&ndash;timolol (preservative-free Cosopt&reg;) in patients with open-angle glaucoma or ocular hypertension
por: Cindy Hutnik, et al.
Publicado: (2010)

Treatment persistence and cost-effectiveness of latanoprost/latanoprost&ndash;timolol, bimatoprost/bimatoprost&ndash;timolol, and travoprost/travoprost&ndash;timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database
por: Antoine Lafuma, et al.
Publicado: (2011)

Travoprost with sofZia® preservative system lowered intraocular pressure of Japanese normal tension glaucoma with minimal side effects
por: Mizoue S, et al.
Publicado: (2014)

Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma
por: Ikeda Y, et al.
Publicado: (2016)

The intraocular pressure-lowering properties of intravenous paracetamol
por: van den Heever H, et al.
Publicado: (2016)

Evolution of visual performance in 70 eyes implanted with the Tecnis&reg; ZMB00 multifocal intraocular lens
por: Palomino Bautista C, et al.
Publicado: (2012)

Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis&reg; noncontact ultra-widefield module versus the Optos&reg; Optomap&reg;
por: Witmer MT, et al.
Publicado: (2013)

Comparison of outcomes of conventional WaveLight&reg; Allegretto Wave&reg; and Technolas&reg; excimer lasers in myopic laser in situ keratomileusis
por: Han DC, et al.
Publicado: (2012)

Difluprednate ophthalmic emulsion 0.05% (Durezol&reg;) administered two times daily for managing ocular inflammation and pain following cataract surgery
por: Stephen Smith, et al.
Publicado: (2010)

Ocular injuries from exploding glass-bottled Coca-Cola&reg; drinks in Port Harcourt, Nigeria
por: Pedro-Egbe CN, et al.
Publicado: (2011)

Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
por: Walimbe T, et al.
Publicado: (2016)

Optical bench performance of AcrySof® IQ ReSTOR®, AT LISA® tri, and FineVision® intraocular lenses
por: Carson D, et al.
Publicado: (2014)

An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan® RC Early Analysis Review (CLEAR) trial
por: Crichton AC, et al.
Publicado: (2014)

Tobramycin administered by the TOBI&reg; Podhaler&reg; for persons with cystic fibrosis: a review
por: VanDevanter DR, et al.
Publicado: (2011)

Patient acceptability of the Tecnis® multifocal intraocular lens
por: Sood P, et al.
Publicado: (2011)

Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients
por: Makoto Ishikawa, et al.
Publicado: (2009)

Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
por: Yelda Buyru &Ouml;zkurt, et al.
Publicado: (2009)

An evaluation of the accuracy of the ORange&reg; (Gen II) by comparing it to the IOLMaster&reg; in the prediction of postoperative refraction
por: Chen M
Publicado: (2012)

Lucentis&reg; using Visudyne&reg; study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration
por: Eric Chen, et al.
Publicado: (2010)

The Effect of Intraocular Pressure-Lowering Medication on Metastatic Uveal Melanomas
por: Jan Pals, et al.
Publicado: (2021)

Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite&reg;) solution in the treatment of ocular infections
por: Utine CA
Publicado: (2011)

Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study
por: Takemoto D, et al.
Publicado: (2017)

Bevacizumab (Avastin&reg;) for the management of anterior chamber neovascularization and neovascular glaucoma
por: Dimitrios Brouzas, et al.
Publicado: (2009)

Latanoprost in the treatment of glaucoma
por: Alm A
Publicado: (2014)

A new device to noninvasively estimate the intraocular pressure produced during ocular compression
por: Korenfeld MS, et al.
Publicado: (2016)

Lowered intraocular pressure in a glaucoma patient after intravitreal injection of ocriplasmin
por: McClintock M, et al.
Publicado: (2015)

Age-related changes of ocular parameters in Korean subjects
por: Dae Woong Lee, et al.
Publicado: (2010)

Azithromycin in DuraSite&reg; for the treatment of blepharitis
por: Jodi Luchs
Publicado: (2010)

Pharmacokinetics of intravitreal bevacizumab (Avastin&reg;) in rabbits
por: Sinapis C, et al.
Publicado: (2011)

The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study
por: Okumichi H, et al.
Publicado: (2017)